Shionogi & Co., Ltd. (SGIOF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 09:30AM EDT
| Previous close | 49.60 |
| Open | 47.83 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 47.83 - 47.83 |
| 52-week range | 40.46 - 53.50 |
| Volume | |
| Avg. volume | 70 |
| Market cap | 13.558B |
| Beta (5Y monthly) | 0.38 |
| PE ratio (TTM) | 13.40 |
| EPS (TTM) | 3.57 |
| Earnings date | 29 Jul 2024 - 02 Aug 2024 |
| Forward dividend & yield | 1.09 (2.28%) |
| Ex-dividend date | 27 Sept 2024 |
| 1y target est | 14.05 |
Globe NewswireF2G and Shionogi Present Full Data Set from Pivotal Phase 2b Study at Trends in Medical Mycology (TIMM) 2023 Demonstrating Positive Therapeutic Responses in Patients with Invasive Fungal Infections Treated with Oral Olorofim
An overall success rate of 28.7% was seen at day 42, the primary endpoint, and 27.2% at day 84, as determined by a data review committee (DRC) using the EORTC-MSG criteriaThe success rate rose to 75.2% at day 42 and 63.4% at day 84 when stable disease was counted as successAll-cause mortality (ACM) at day 42 and day 84 was 11.4% and 15.8%, respectively MANCHESTER, United Kingdom and OSAKA, Japan, Oct. 21, 2023 (GLOBE NEWSWIRE) -- F2G Ltd. and Shionogi & Co., Ltd., today announced full results fr
© 2024 Yahoo. All rights reserved.